tiprankstipranks
Oric Pharmaceuticals Inc (ORIC)
NASDAQ:ORIC
US Market
ORIC
Oric Pharmaceuticals
RESEARCH TOOLSreports
Want to see ORIC full AI Analyst Report?

Oric Pharmaceuticals (ORIC) Stock News & Sentiment

520 Followers
ORIC Pharma: Buy Rating on Rinzimetostat’s Promising Efficacy, Favorable Safety, and 2026 MEVPRO-1 Readout Catalyst
Premium
Ratings
ORIC Pharma: Buy Rating on Rinzimetostat’s Promising Efficacy, Favorable Safety, and 2026 MEVPRO-1 Readout Catalyst
9d ago
ORIC
ORIC Pharmaceuticals: Buy Rating Backed by Advancing Oncology Pipeline, Phase 3 Prostate Cancer Trial and 2026 NSCLC Data Catalysts
Premium
Ratings
ORIC Pharmaceuticals: Buy Rating Backed by Advancing Oncology Pipeline, Phase 3 Prostate Cancer Trial and 2026 NSCLC Data Catalysts
19d ago
ORIC
3 Best Stocks to Buy amid the Market Pullback, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy amid the Market Pullback, According to Top Analysts
2M ago
ENGN
ORIC
Oric Advances Rinzimetostat Toward First Prostate Cancer Phase 3
Premium
Company Announcements
Oric Advances Rinzimetostat Toward First Prostate Cancer Phase 3
2M ago
8K
ORIC
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
Premium
Ratings
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
2M ago
ORIC
ORIC Pharmaceuticals: Differentiated PRC2 Inhibitor Rinzimetostat Mitigates Sector Safety Overhang and Supports Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Differentiated PRC2 Inhibitor Rinzimetostat Mitigates Sector Safety Overhang and Supports Buy Rating
3M ago
ORIC
Oric Pharmaceuticals Launches New 2026 ATM Share Program
Premium
Company Announcements
Oric Pharmaceuticals Launches New 2026 ATM Share Program
3M ago
8K
ORIC
More ORIC News >

ORIC News on the Web

Here are Friday's biggest analyst calls: Nvidia, Alphabet, Dell, Cisco, Netflix, Texas Roadhouse, J.M. Smucker & more
CNBC
Neutral
ORIC Pharma: Buy Rating on Rinzimetostat’s Promising Efficacy, Favorable Safety, and 2026 MEVPRO-1 Readout Catalyst
TipRanks News
Bullish
Oric Pharmaceuticals moved to Buy rating at Goldman Sachs
TipRanks News
Bullish
Oric Pharmaceuticals (ORIC) Initiated with a Buy at Wedbush
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Fortrea Holdings Inc. (FTRE) and Edwards Lifesciences (EW)
TipRanks News
Bullish
ORIC Pharmaceuticals: Buy Rating Backed by Advancing Oncology Pipeline, Phase 3 Prostate Cancer Trial and 2026 NSCLC Data Catalysts
TipRanks News
Bullish
Piper Sandler Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC)
TipRanks News
Bullish
Guggenheim Remains a Buy on Oric Pharmaceuticals (ORIC)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ORIC’s Media Buzz Sentiment?
Currently, no data Available
What is ORIC’s weekly average amount of articles?
In an average week, 2.75 articles about ORIC are published.
    What is ORIC’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GOSSGossamer Bio
    RLAYRelay Therapeutics
    ROIVRoivant Sciences
    ILAIsland Pharmaceuticals Ltd
    TLSATiziana Life Sciences
    Showing the stocks with the most bullish news sentiment over the past week